{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:41:38Z","timestamp":1792806098549,"version":"4.5.0"},"reference-count":30,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The object of this study was to ascertain outcomes of cochlear implantation (CI) following stereotactic radiosurgery (SRS) for vestibular schwannoma (VS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a retrospective chart review of adult patients with VS treated with SRS who underwent CI between 1990 and 2019 at a single tertiary care referral center. Patient demographics, tumor features, treatment parameters, and pre- and postimplantation audiometric and clinical outcomes are presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Seventeen patients (18 ears) underwent SRS and ipsilateral CI during the study period. Thirteen patients (76%) had neurofibromatosis type 2 (NF2). Median age at SRS and CI were 44 and 48 years, respectively. Median time from SRS to CI was 60 days, but notably, 4 patients underwent SRS and CI within 1 day and 5 patients underwent CI more than 7 years after SRS. Median marginal dose was 13 Gy. Median treatment volume at the time of SRS was 1400 mm\n                      <jats:sup>3<\/jats:sup>\n                      (range 84\u20136080 mm\n                      <jats:sup>3<\/jats:sup>\n                      , n = 15 patients). Median post-CI PTA was 28 dB HL, improved from 101 dB HL preoperatively (p &lt; 0.001). Overall, 11 patients (12 ears) exhibited open-set speech understanding. Sentence testing was performed at a median of 10 months (range 1\u2013143 months) post-CI. The median AzBio sentence score for patients with open-set speech understanding was 76% (range 19%\u201395%, n = 10 ears). Two ears exhibited Hearing in Noise Test (HINT) sentence scores of 49% and 95%, respectively. Four patients achieved environmental sound awareness without open-set speech recognition. Two had no detectable auditory percepts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Most patients who underwent CI following SRS for VS enjoyed access to sound at near-normal levels, with the majority achieving good open-set speech understanding. Implantation can be performed immediately following SRS or in a delayed fashion, depending on hearing status as well as other factors. This strategy may be applied to cases of sporadic or NF2-associated VS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.4.jns201069","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T03:42:27Z","timestamp":1595562147000},"page":"126-135","source":"Crossref","is-referenced-by-count":18,"title":["Cochlear implantation after radiosurgery for vestibular schwannoma"],"prefix":"10.3171","volume":"135","author":[{"given":"Neil S.","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Neff","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie J.","family":"Van Gompel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L. W.","family":"Driscoll","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, and"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Orphanet J Rare Dis","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans\n \nDG","year":"2009","unstructured":"Evans\n \nDG\n\n\n. \nNeurofibromatosis type 2 (NF2): a clinical and molecular review\n. \nOrphanet J Rare Dis\n. \n2009\n;\n4\n:\n16\n.\n1954537810.1186\/1750-1172-4-16"},{"issue":"9","key":"b2","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/MAO.0000000000001166","article-title":"Auditory brainstem implantation in neurofibromatosis type 2: experience from the Manchester Programme","volume":"37","author":"Ramsden\n \nRT","year":"2016","unstructured":"Ramsden\n \nRT\n\n, \n\nFreeman\n \nSRM\n\n, \n\nLloyd\n \nSKW\n\n, \n\n\n \nAuditory brainstem implantation in neurofibromatosis type 2: experience from the Manchester Programme\n. \nOtol Neurotol\n. \n2016\n;\n37\n(\n9\n):\n1267\n\u2013\n1274\n.\n10.1097\/MAO.000000000000116627525707"},{"issue":"6","key":"b3","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MLG.0b013e31804b1ae7","article-title":"Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up","volume":"117","author":"Neff\n \nBA","year":"2007","unstructured":"Neff\n \nBA\n\n, \n\nWiet\n \nRM\n\n, \n\nLasak\n \nJM\n\n, \n\n\n \nCochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up\n. \nLaryngoscope\n. \n2007\n;\n117\n(\n6\n):\n1069\n\u2013\n1072\n.\n1754586910.1097\/MLG.0b013e31804b1ae7"},{"issue":"3","key":"b4","series-title":"Otolaryngol Head Neck Surg","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0194-5998(95)70101-X","volume":"113","author":"Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma)","year":"1995","unstructured":"Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma)\n\n\n. \nOtolaryngol Head Neck Surg\n. \n1995\n;\n113\n(\n3\n):\n179\n\u2013\n180\n.\n10.1016\/S0194-5998(95)70101-X"},{"issue":"1","key":"b5","series-title":"Otolaryngol Head Neck Surg","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0194599812437156","article-title":"Is it valid to calculate the 3-kilohertz threshold by averaging 2 and 4 kilohertz?","volume":"147","author":"Gurgel\n \nRK","year":"2012","unstructured":"Gurgel\n \nRK\n\n, \n\nPopelka\n \nGR\n\n, \n\nOghalai\n \nJS\n\n, \n\n\n \nIs it valid to calculate the 3-kilohertz threshold by averaging 2 and 4 kilohertz?\n \nOtolaryngol Head Neck Surg\n. \n2012\n;\n147\n(\n1\n):\n102\n\u2013\n104\n.\n2230110210.1177\/0194599812437156"},{"issue":"5","key":"b6","series-title":"Arch Otolaryngol Head Neck Surg","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/archotol.130.5.624","article-title":"Performance of subjects fit with the Advanced Bionics CII and Nucleus 3G cochlear implant devices","volume":"130","author":"Spahr\n \nAJ","year":"2004","unstructured":"Spahr\n \nAJ\n\n, \n\nDorman\n \nMF\n\n\n. \nPerformance of subjects fit with the Advanced Bionics CII and Nucleus 3G cochlear implant devices\n. \nArch Otolaryngol Head Neck Surg\n. \n2004\n;\n130\n(\n5\n):\n624\n\u2013\n628\n.\n10.1001\/archotol.130.5.62415148187"},{"issue":"1","key":"b7","series-title":"Ear Hear","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/AUD.0b013e31822c2549","article-title":"Development and validation of the AzBio sentence lists","volume":"33","author":"Spahr\n \nAJ","year":"2012","unstructured":"Spahr\n \nAJ\n\n, \n\nDorman\n \nMF\n\n, \n\nLitvak\n \nLM\n\n, \n\n\n \nDevelopment and validation of the AzBio sentence lists\n. \nEar Hear\n. \n2012\n;\n33\n(\n1\n):\n112\n\u2013\n117\n.\n2182913410.1097\/AUD.0b013e31822c2549"},{"issue":"5","key":"b8","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/MAO.0b013e318254fba5","article-title":"Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance","volume":"33","author":"Carlson\n \nML","year":"2012","unstructured":"Carlson\n \nML\n\n, \n\nBreen\n \nJT\n\n, \n\nDriscoll\n \nCL\n\n, \n\n\n \nCochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance\n. \nOtol Neurotol\n. \n2012\n;\n33\n(\n5\n):\n853\n\u2013\n862\n.\n10.1097\/MAO.0b013e318254fba522664900"},{"issue":"8","key":"b9","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/lary.23928","article-title":"Primary inner ear schwannomas: a case series and systematic review of the literature","volume":"123","author":"Van Abel\n \nKM","year":"2013","unstructured":"Van Abel\n \nKM\n\n, \n\nCarlson\n \nML\n\n, \n\nLink\n \nMJ\n\n, \n\n\n \nPrimary inner ear schwannomas: a case series and systematic review of the literature\n. \nLaryngoscope\n. \n2013\n;\n123\n(\n8\n):\n1957\n\u2013\n1966\n.\n2333515210.1002\/lary.23928"},{"issue":"6","key":"b10","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/MAO.0000000000000666","article-title":"magnetic resonance imaging with cochlear implant magnet in place: safety and imaging quality","volume":"36","author":"Carlson\n \nML","year":"2015","unstructured":"Carlson\n \nML\n\n, \n\nNeff\n \nBA\n\n, \n\nLink\n \nMJ\n\n, \n\n\n \nmagnetic resonance imaging with cochlear implant magnet in place: safety and imaging quality\n. \nOtol Neurotol\n. \n2015\n;\n36\n(\n6\n):\n965\n\u2013\n971\n.\n10.1097\/MAO.000000000000066625931165"},{"issue":"5","key":"b11","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.1097\/MAO.0000000000002569","article-title":"Performing MRI scans on cochlear implant and auditory brainstem implant recipients: review of 14.5 years experience","volume":"41","author":"Tam\n \nYC","year":"2020","unstructured":"Tam\n \nYC\n\n, \n\nLee\n \nJWY\n\n, \n\nGair\n \nJ\n\n, \n\n\n \nPerforming MRI scans on cochlear implant and auditory brainstem implant recipients: review of 14.5 years experience\n. \nOtol Neurotol\n. \n2020\n;\n41\n(\n5\n):\ne556\n\u2013\ne562\n.\n10.1097\/MAO.000000000000256931985706"},{"issue":"6","key":"b12","series-title":"J Neurol Surg B Skull Base","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1055\/s-0038-1676768","article-title":"cochlear implantation in sporadic vestibular schwannoma: a systematic literature review","volume":"80","author":"Bartindale\n \nMR","year":"2019","unstructured":"Bartindale\n \nMR\n\n, \n\nTadokoro\n \nKS\n\n, \n\nKircher\n \nML\n\n\n. \ncochlear implantation in sporadic vestibular schwannoma: a systematic literature review\n. \nJ Neurol Surg B Skull Base\n. \n2019\n;\n80\n(\n6\n):\n632\n\u2013\n639\n.\n3175005010.1055\/s-0038-1676768"},{"issue":"1","key":"b13","series-title":"Cochlear Implants Int","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14670100.2019.1662161","article-title":"Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: a systematic review","volume":"21","author":"Borsetto\n \nD","year":"2020","unstructured":"Borsetto\n \nD\n\n, \n\nHammond-Kenny\n \nA\n\n, \n\nTysome\n \nJR\n\n, \n\n\n \nHearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: a systematic review\n. \nCochlear Implants Int\n. \n2020\n;\n21\n(\n1\n):\n9\n\u2013\n17\n.\n10.1080\/14670100.2019.1662161"},{"issue":"9","key":"b14","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/lary.27181","article-title":"Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2","volume":"128","author":"Peng\n \nKA","year":"2018","unstructured":"Peng\n \nKA\n\n, \n\nLorenz\n \nMB\n\n, \n\nOtto\n \nSR\n\n, \n\n\n \nCochlear implantation and auditory brainstem implantation in neurofibromatosis type 2\n. \nLaryngoscope\n. \n2018\n;\n128\n(\n9\n):\n2163\n\u2013\n2169\n.\n10.1002\/lary.2718129573425"},{"issue":"2","key":"b15","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MAO.0b013e318241bc71","article-title":"Auditory brainstem implants in NF2 patients: results and review of the literature","volume":"33","author":"Sanna\n \nM","year":"2012","unstructured":"Sanna\n \nM\n\n, \n\nDi Lella\n \nF\n\n, \n\nGuida\n \nM\n\n, \n\nMerkus\n \nP\n\n\n. \nAuditory brainstem implants in NF2 patients: results and review of the literature\n. \nOtol Neurotol\n. \n2012\n;\n33\n(\n2\n):\n154\n\u2013\n164\n.\n10.1097\/MAO.0b013e318241bc7122246383"},{"issue":"5","key":"b16","series-title":"ORL J Otorhinolaryngol Relat Spec","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000350568","article-title":"Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients","volume":"75","author":"Matthies\n \nC","year":"2013","unstructured":"Matthies\n \nC\n\n, \n\nBrill\n \nS\n\n, \n\nKaga\n \nK\n\n, \n\n\n \nAuditory brainstem implantation improves speech recognition in neurofibromatosis type II patients\n. \nORL J Otorhinolaryngol Relat Spec\n. \n2013\n;\n75\n(\n5\n):\n282\n\u2013\n295\n.\n2404284610.1159\/000350568"},{"issue":"3","key":"b17","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1227\/NEU.0000000000000264","article-title":"Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes","volume":"74","author":"Mallory\n \nGW","year":"2014","unstructured":"Mallory\n \nGW\n\n, \n\nPollock\n \nBE\n\n, \n\nFoote\n \nRL\n\n, \n\n\n \nStereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes\n. \nNeurosurgery\n. \n2014\n;\n74\n(\n3\n):\n292\n\u2013\n301\n.\n2433581910.1227\/NEU.0000000000000264"},{"issue":"2","key":"b18","series-title":"Cochlear Implants Int","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1179\/1754762810Y.0000000003","article-title":"Cochlear implant rehabilitation for patients with vestibular schwannoma: report of two cases","volume":"13","author":"Amoodi\n \nHA","year":"2012","unstructured":"Amoodi\n \nHA\n\n, \n\nMakki\n \nFM\n\n, \n\nCavanagh\n \nJ\n\n, \n\n\n \nCochlear implant rehabilitation for patients with vestibular schwannoma: report of two cases\n. \nCochlear Implants Int\n. \n2012\n;\n13\n(\n2\n):\n124\n\u2013\n127\n.\n10.1179\/1754762810Y.000000000322152982"},{"issue":"1","key":"b19","series-title":"J Radiosurg SBRT","first-page":"69","article-title":"Cochlear implantation after radiation therapy for acoustic neuroma","volume":"4","author":"Costello\n \nMS","year":"2016","unstructured":"Costello\n \nMS\n\n, \n\nGolub\n \nJS\n\n, \n\nBarrord\n \nJV\n\n, \n\n\n \nCochlear implantation after radiation therapy for acoustic neuroma\n. \nJ Radiosurg SBRT\n. \n2016\n;\n4\n(\n1\n):\n69\n\u2013\n74\n.\n29296428"},{"issue":"4","key":"b20","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00129492-200606000-00013","article-title":"Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma","volume":"27","author":"Lustig\n \nLR","year":"2006","unstructured":"Lustig\n \nLR\n\n, \n\nYeagle\n \nJ\n\n, \n\nDriscoll\n \nCL\n\n, \n\n\n \nCochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma\n. \nOtol Neurotol\n. \n2006\n;\n27\n(\n4\n):\n512\n\u2013\n518\n.\n1679104310.1097\/00129492-200606000-00013"},{"issue":"7","key":"b21","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/MAO.0b013e31829763a7","article-title":"Cochlear implants to treat deafness caused by vestibular schwannomas","volume":"34","author":"Mukherjee\n \nP","year":"2013","unstructured":"Mukherjee\n \nP\n\n, \n\nRamsden\n \nJD\n\n, \n\nDonnelly\n \nN\n\n, \n\n\n \nCochlear implants to treat deafness caused by vestibular schwannomas\n. \nOtol Neurotol\n. \n2013\n;\n34\n(\n7\n):\n1291\n\u2013\n1298\n.\n10.1097\/MAO.0b013e31829763a723921933"},{"issue":"8","key":"b22","series-title":"Laryngoscope","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/lary.24056","article-title":"Cochlear implantation in patients with vestibular schwannoma: a single United Kingdom center experience","volume":"123","author":"Pai\n \nI","year":"2013","unstructured":"Pai\n \nI\n\n, \n\nDhar\n \nV\n\n, \n\nKelleher\n \nC\n\n, \n\n\n \nCochlear implantation in patients with vestibular schwannoma: a single United Kingdom center experience\n. \nLaryngoscope\n. \n2013\n;\n123\n(\n8\n):\n2019\n\u2013\n2023\n.\n2361608510.1002\/lary.24056"},{"issue":"2","key":"b23","series-title":"Rev Bras Otorrinolaringol (Engl Ed).","first-page":"242","article-title":"Cochlear implant in a patient with neurofibromatosis type 2 undergoing radiotherapy","volume":"82","author":"Pimentel\n \nPS","year":"2016","unstructured":"Pimentel\n \nPS\n\n, \n\nRamos\n \nDS\n\n, \n\nMuniz\n \nL\n\n, \n\n\n \nCochlear implant in a patient with neurofibromatosis type 2 undergoing radiotherapy\n. \nRev Bras Otorrinolaringol (Engl Ed).\n \n2016\n;\n82\n(\n2\n):\n242\n\u2013\n243\n."},{"issue":"1","key":"b24","series-title":"J Radiosurg SBRT","first-page":"63","article-title":"Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II","volume":"5","author":"Pisa\n \nJ","year":"2017","unstructured":"Pisa\n \nJ\n\n, \n\nSulkers\n \nJ\n\n, \n\nButler\n \nJB\n\n, \n\n\n \nStereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II\n. \nJ Radiosurg SBRT\n. \n2017\n;\n5\n(\n1\n):\n63\n\u2013\n71\n."},{"issue":"4","key":"b25","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3171\/2011.5.JNS101929","article-title":"Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants","volume":"115","author":"Roehm\n \nPC","year":"2011","unstructured":"Roehm\n \nPC\n\n, \n\nMallen-St Clair\n \nJ\n\n, \n\nJethanamest\n \nD\n\n, \n\n\n \nAuditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants\n. \nJ Neurosurg\n. \n2011\n;\n115\n(\n4\n):\n827\n\u2013\n834\n.\n10.3171\/2011.5.JNS10192921761973"},{"issue":"11","key":"b26","series-title":"Eur Arch Otorhinolaryngol","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00405-018-5127-9","article-title":"Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2","volume":"275","author":"Tan\n \nH","year":"2018","unstructured":"Tan\n \nH\n\n, \n\nJia\n \nH\n\n, \n\nLi\n \nY\n\n, \n\n\n \nImpact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2\n. \nEur Arch Otorhinolaryngol\n. \n2018\n;\n275\n(\n11\n):\n2667\n\u2013\n2674\n.\n10.1007\/s00405-018-5127-930229456"},{"issue":"4","key":"b27","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1097\/MAO.0000000000002165","article-title":"Cochlear implantation in patients with neurofibromatosis type 2","volume":"40","author":"Tolisano\n \nAM","year":"2019","unstructured":"Tolisano\n \nAM\n\n, \n\nBaumgart\n \nB\n\n, \n\nWhitson\n \nJ\n\n, \n\nKutz\n \nJW\n \nJr\n\n\n. \nCochlear implantation in patients with neurofibromatosis type 2\n. \nOtol Neurotol\n. \n2019\n;\n40\n(\n4\n):\ne381\n\u2013\ne385\n.\n10.1097\/MAO.000000000000216530870359"},{"issue":"9","key":"b28","series-title":"Acta Otolaryngol","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/00016480802510202","article-title":"Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2","volume":"129","author":"Tran Ba Huy\n \nP","year":"2009","unstructured":"Tran Ba Huy\n \nP\n\n, \n\nKania\n \nR\n\n, \n\nFrachet\n \nB\n\n, \n\n\n \nAuditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2\n. \nActa Otolaryngol\n. \n2009\n;\n129\n(\n9\n):\n971\n\u2013\n975\n.\n10.1080\/0001648080251020219016361"},{"issue":"2","key":"b29","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MAO.0b013e3181c348e7","article-title":"Cochlear implantation in neurofibromatosis type 2 after radiation therapy","volume":"31","author":"Trotter\n \nMI","year":"2010","unstructured":"Trotter\n \nMI\n\n, \n\nBriggs\n \nRJS\n\n\n. \nCochlear implantation in neurofibromatosis type 2 after radiation therapy\n. \nOtol Neurotol\n. \n2010\n;\n31\n(\n2\n):\n216\n\u2013\n219\n.\n10.1097\/MAO.0b013e3181c348e719887974"},{"issue":"2","key":"b30","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3171\/2013.9.JNS12686","article-title":"Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?","volume":"120","author":"Matthies\n \nC","year":"2014","unstructured":"Matthies\n \nC\n\n, \n\nBrill\n \nS\n\n, \n\nVarallyay\n \nC\n\n, \n\n\n \nAuditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?\n \nJ Neurosurg\n. \n2014\n;\n120\n(\n2\n):\n546\n\u2013\n558\n.\n10.3171\/2013.9.JNS1268624329026"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p126.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p126.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p126.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:49:37Z","timestamp":1792802977000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/1\/article-p126.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":30,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2020.4.jns201069","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}